<DOC>
	<DOCNO>NCT02032368</DOCNO>
	<brief_summary>Circulating tumour cell ( CTC ) count could reflect effect postoperative transarterial chemoembolization ( TACE ) hepatocellular carcinoma ( HCC ) recurrence .</brief_summary>
	<brief_title>Decrease Circulating Tumour Cell Count Reflects Effectiveness Postoperative Adjuvant Transarterial Chemoembolization ( TACE ) Preventing Hepatocellular Carcinoma Recurrence</brief_title>
	<detailed_description>Early metastasis hepatocellular carcinoma ( HCC ) may detect isolation circulate tumor cell ( CTCs ) bloodstream . During course therapeutic attempt , monitor CTC change patient HCC helpful efficacy assessment . Nevertheless , marker use detection , a-feto protein , asialoglycoprotein receptor epithelial cell adhesion molecule , CD133 CD90 , specific HCC CTCs . In spite limitation , timely determination existence CTCs beneficial monitoring distant metastasis , evaluation therapeutic attempt , prediction prognosis .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>definitive pathological diagnosis HCC base World Health Organization ( WHO ) criteria ; underwent curative resection one month ago , CT MRI detect new lesion recruit ; CTC counts≥2 resection ; age 18 75 year ; adequate hematologic function ( platelet count : &gt; 60 × 109 platelets/L ; hemoglobin : &gt; 90g/L ; prothrombin time : &lt; 3 second control ) ; adequate renal function ( serum creatinine : ≤1.5 × upper limit normal ) ; ChildPugh classification A B grade hypovascular tumor ( defined tumor part less contrastenhanced nontumorous liver parenchyma arterial phase compute tomography scan ) ; diffusetype HCC ; evidence hepatic decompensation include esophageal gastric variceal bleed hepatic encephalopathy ; severe underlie cardiac renal disease ; color Doppler ultrasonography show portal vein tumor thrombosis complete main portal vein obstruction without cavernous transformation ; obstructive jaundice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>circulate tumour cell ;</keyword>
	<keyword>transarterial chemoembolization ;</keyword>
	<keyword>hepatocellular carcinoma ;</keyword>
	<keyword>recurrence</keyword>
</DOC>